No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
Updated: 2026-05-29 · v2.0 · Prof. G. Pkhakadze, MD, MPH, PhDCiteEditorial
📰Read the full L-Phenylalanine evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.
2
Conditional
L-Phenylalanine
L-Phenylalanine / DL-Phenylalanine
Conditionally SafeModerateAmino Acids
RDA
Typical 500–1,500 mg
Target
120–360 µmol/L
Upper limit
No UL
Products
8
Dosage by population group — reference
🔗 Best with: L-Tyrosine, Vitamin B6 (Pyridoxine), Vitamin C✅ USP Verified, NSF Certified for Sport, Informed Sport
⚠ PKU patient given phenylalanine supplement — ABSOLUTE contraindication [1]
⚠ Patient on MAOIs adding phenylalanine — hypertensive crisis risk [1]
⚠ Patient on levodopa (Parkinson's) — phenylalanine competes for transport [1]
⚠ Patient taking phenylalanine with meals — empty stomach needed for brain uptake [1]
🥗 Food first — build your daily Typical 500–1,500 mg
Check the foods you regularly eat — the bar fills toward your daily target.
Chicken breast (100 g)1,200 mg L-phenylalanine
Soybeans (100 g)2,000 mg L-phenylalanine
Cheese (100 g)1,500 mg L-phenylalanine
Eggs (2 large)700 mg L-phenylalanine
Almonds (30 g)400 mg L-phenylalanine
0 mg L-phenylalanine
Check your regular foods above
🔬 Lab interpreter
Recommended test
Plasma phenylalanine (if PKU concern)
Reference range / target
120–360 µmol/L (normal)
When to test
Before starting supplementation in any at-risk individual [1].
Universal newborn screening should have identified PKU [1].
Full lab monitoring ↓
⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
L-Phenylalanine is a catecholamine precursor (→ dopamine → norepinephrine) with dated RCT evidence for depression. DL-PA adds D-form endorphin modulation for pain. The ONE non-negotiable clinical rule: ABSOLUTE contraindication in PKU — screen before recommending. The MAOI interaction (hypertensive crisis) is the other critical safety point [1].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
Dietary phenylalanine essential. Supplement doses: caution. Maternal PKU requires strict restriction [1].
👦 Pediatric: See guidance
Do not supplement in children without metabolic specialist guidance. PKU screening is universal at birth [1].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose

How to take

🍽 Timing: On empty stomach, 30 min before meals [1].
💊 With food: AVOID food (amino acid transport competition) [1].
🚫 Avoid: PKU patients. MAOI users. With levodopa. With meals [1].
2 Which form?
FormBioavailabilityVeganCost
['L-Phenylalanine capsules', 'standard', '500 mg, 1–3 capsules/day. Catecholamine precursor. Take on empty stomach [1].']StandardCheck label
['DL-Phenylalanine (DLPA)', 'pain/mood', 'Combines L-form (catecholamine) and D-form (endorphin degradation inhibitor). 375–750 mg BID–TID [1].']StandardCheck label
['D-Phenylalanine (DPA)', 'specialized', 'D-form only. Inhibits enkephalinase, prolonging endogenous opioid peptide activity. Less common [1].']StandardCheck label
3 Common questions
What is the difference between L-, D-, and DL-Phenylalanine?
L-Phenylalanine: the natural dietary form; precursor to tyrosine/dopamine/norepinephrine. D-Phenylalanine: synthetic mirror image; inhibits enkephalinase (enzyme that degrades endorphins), potentially prolonging pain relief. DL-Phenylalanine (DLPA): 50:50 mix combining both mechanisms — catecholamine support AND endorphin modulation [1].
Is DLPA safe if I have PKU?
ABSOLUTELY NOT. Any form of phenylalanine supplementation is contraindicated in PKU. Phenylalanine cannot be metabolized and accumulates to neurotoxic levels. This includes aspartame-containing products (aspartame releases phenylalanine) [1].
Can L-Phenylalanine help depression?
The catecholamine hypothesis of depression provides a mechanistic rationale: phenylalanine → dopamine/norepinephrine. Small 1970s–80s RCTs showed benefit comparable to tricyclic antidepressants. However, modern evidence is lacking, and L-Phenylalanine should not replace evidence-based antidepressant therapy [1].
Why take it on an empty stomach?
Large neutral amino acids compete for intestinal and blood-brain barrier transport (LAT1 transporter). Taking phenylalanine with protein-rich food means competition with dietary amino acids, reducing brain uptake. Empty stomach maximizes catecholamine precursor delivery to the brain [1].
4 Clinical evidence

Strong

Catecholamine precursor biochemistry is well-established. PKU screening is universal in newborns in developed countries [1]. HIGH

Moderate

Depression: 2 small RCTs of DL-PA showed improvement comparable to imipramine in mild-moderate depression, though studies are dated (1970s–80s) and small [1]. Chronic pain: D-phenylalanine inhibits enkephalinase, theoretically prolonging endogenous opioid activity. Clinical evidence limited to case series [1]. Vitiligo: L-phenylalanine + UVA exposure improved repigmentation in 2 small studies [1]. MODERATE

Insufficient

ADHD: catecholamine precursor loading is theoretically relevant but no modern RCTs [1]. Parkinson's (early stage): tyrosine/phenylalanine loading competes with levodopa — potentially harmful [1]. Weight loss: catecholamine appetite suppression is theoretical only [1]. LOW
5 Safety, toxicity & adverse events

Absolute contraindications

✕ Phenylketonuria (PKU) — cannot metabolize phenylalanine
✕ Concurrent MAOIs — hypertensive risk

Relative

⚠ Hyperthyroidism — precursor to thyroid hormone/catecholamines
⚠ Schizophrenia or tardive dyskinesia — may worsen
⚠ Pregnancy — avoid high supplemental doses (especially if PKU carrier)

🚩 Red flags

ANY phenylalanine supplementation in PKU — CONTRAINDICATED [1]
Patient on MAOI + phenylalanine — hypertensive crisis [1]
Patient experiencing anxiety/agitation — dose too high [1]
6 Interactions

Drug interactions

MAO inhibitors (phenelzine, tranylcypromine) Major
Mechanism: Phenylalanine increases catecholamine synthesis; MAOIs prevent breakdown [1].
Effect: Hypertensive crisis (tyramine-like reaction) [1].
Action: CONTRAINDICATED combination [1].
Levodopa Major
Mechanism: Competition for LAT1 intestinal and BBB transport [1].
Effect: Reduced levodopa efficacy [1].
Action: Avoid phenylalanine supplements in Parkinson's patients on levodopa [1].

Supplement synergies

Vitamin B6 + Vitamin C · 50 mg B6 + 500 mg C with phenylalanine
B6 is cofactor for aromatic amino acid decarboxylase; C is cofactor for dopamine β-hydroxylase. Both support catecholamine synthesis from phenylalanine [1].
7 Regulatory
United States (FDA): Available as dietary supplement. Aspartame labeling must include PKU warning [1].
PKU screening: Universal newborn screening in >50 countries. One of the oldest metabolic disorder screens (Guthrie test, 1963) [1].
8 US supplement products
8
on-market products containing L-Phenylalanine (NIH DSLD)

Brands carrying L-Phenylalanine (2)

Click a brand to see its L-Phenylalanine products.
Or browse all 8 products in one list →
9 Frequently paired with
L-Tyrosine 6 sharedL-Tryptophan 4 sharedL-Leucine 4 sharedL-Lysine 4 shared
L-Phenylalanine vs L-TyrosineL-Phenylalanine vs Vitamin B6
10 Cite this page
Vancouver: Pkhakadze G. L-Phenylalanine — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Jul 15]. Available from: https://supplement.ge/ingredients/l-phenylalanine/
APA 7th: Pkhakadze, G. (2026). L-Phenylalanine — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/l-phenylalanine/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: January 2027
References: 4 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "L-Phenylalanine — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/l-phenylalanine/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG